Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes

Published: January 10, 2022

Stethoscope with blood sugar control glucometer glucose meter, fruits and dumbbells
  • This scientific statement provides an update to all the latest clinical trials until June 2020 that examined cardiovascular risk management through individual and population level interventions to increase control of cardiovascular risk factors in persons with type 2 diabetes mellitus (T2D)
  • The statement addresses the continued importance of lifestyle interventions, pharmacologic therapy, and surgical interventions to curb the epidemic of obesity and metabolic syndrome, important precursors of prediabetes, T2D and comorbid cardiovascular disease.
  • The statement also explores the critical importance of the social determinants of health and health equity in the continuum of care in persons with T2D and cardiovascular disease.